The aim of this clinical trial is to evaluate the ability of a dietary supplement based on salicornia extracts and B vitamins (B-Salicornia) to modulate lipid levels in a population with newly diagnosed dyslipidemia who are not eligible for medical treatment.
Participants aged 40 to 65
Newly diagnosed dyslipidemia (two years) with SCORE ≥1 - <5 (LDL 116 - <190 mg/dL): Moderate Risk
No indication for pharmacological treatment in primary prevention.
Possibility of performing analytical controls at the beginning/end of the study.
Participants with vascular risk requiring pharmacological treatment or high/very high vascular risk.
Participants in secondary prevention.
Hyperthyroidism according to the researcher's criteria.
Taking vitamin B supplements and/or supplements containing polyphenols in the 30 days prior to the screening visit (at the researcher's discretion).
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Lead sponsor
Joan Montaner Villalonga
Collaborator